Laurent Fischer - Sep 19, 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role: CEO, President and Director, Director
Signature: Laurent D. Fischer, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol: ADVM
Transactions as of: Sep 19, 2022
Transactions value $: -$43,941
Form type: 4
Date filed: 9/21/2022, 07:57 PM
Previous filing: Sep 16, 2022
Next filing: Mar 3, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADVM	Common Stock	Sale	-$43.9K	-41.1K	-5.35%	$1.07	727K	Sep 19, 2022	Direct	F1, F2, F3

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
F2	Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.0708. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3	Includes 6,000 shares purchased on May 20, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.